In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German leukemia study groups

Background. The t(9;22)(q34;q11) translocation leading to the Philadelphia (Ph) chromosome resulting in BCR-ABL gene fusion is associated with a poor prognosis in acute lymphoblastic leukemia (ALL). Procedure. We studied the relation between t(9;22), determined by karyotype, fluorescence in situ hybridization (FISH) or polymerase chain reaction (PCR), and in vitro drug resistance, measured by the MTT assay, in precursor B-cell ALL at diagnosis. The findings in twenty-one Ph-positive (Ph+) childhood common/precursorB (c/preB) cases were compared with 254 Ph-negative (Ph-) ALL cases. Results. A large range of LC50 values was found within the Ph+ patients. Moreover, LC50 values did not differ significantly between Ph+ and Ph- samples for prednisolone, dexamethasone, L-asparaginase, vincristine, anthracycline,, thiupurines, epipodophyllotoxins, and 4H00-ifosfamide, even after matching for important prognostic features (age, white blood cell count (WBC, and immunopheno-type). Adult Ph+ (n - 12) ALL was more resistant to prednisolone (>270-fold, P = 0.030), and displayed an overall tendency to resistance when compared to matched cases of Ph(n = 15) adult precursor B-cell ALL. Within Ph+ ALL, in vitro prednisolone resistance increased significantly with age (P = 0.006). The expression of lung resistance protein (LRP), but not P-glycoprotein (P-gp) or multidrug resistance protein (MRP), was significantly higher in all Ph-, patients. Conclusions. Both childhood and adult Ph+ precursor B-cell ALL sample, display a heterogeneous in vitro resistance profile, with relatively sensitive and resistant cases. The adult Ph-, samples, however, are generally more resistant compared to matched Ph- controls, reaching significance for prednisolone. The correlation of prednisolone resistance with age within the Ph+ cases might help explain the poorer prognosis of adult Ph+ ALL. Med Pediatr Oncol 2002;38:379-386. (C) 2002 Wiley-Liss, Inc.